U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
KB-003
Preferred Name English
LENZILUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CSF2 (COLONY STIMULATING FACTOR 2 (GRANULOCYTE-MACROPHAGE), GRANULOCYTEMACROPHAGE COLONY STIMULATING FACTOR, GM-CSF)), HOMO SAPIENS MONOCLONAL ANTIBODY
Common Name English
lenzilumab [INN]
Common Name English
LENZILUMAB [USAN]
Common Name English
Lenzilumab [WHO-DD]
Common Name English
KB003
Code English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 22:41:04 GMT 2025 , Edited by admin on Mon Mar 31 22:41:04 GMT 2025
NCI_THESAURUS C129822
Created by admin on Mon Mar 31 22:41:04 GMT 2025 , Edited by admin on Mon Mar 31 22:41:04 GMT 2025
Code System Code Type Description
ChEMBL
CHEMBL3707325
Created by admin on Mon Mar 31 22:41:04 GMT 2025 , Edited by admin on Mon Mar 31 22:41:04 GMT 2025
PRIMARY
INN
9965
Created by admin on Mon Mar 31 22:41:04 GMT 2025 , Edited by admin on Mon Mar 31 22:41:04 GMT 2025
PRIMARY
DRUG BANK
DB15148
Created by admin on Mon Mar 31 22:41:04 GMT 2025 , Edited by admin on Mon Mar 31 22:41:04 GMT 2025
PRIMARY
CAS
1229575-09-0
Created by admin on Mon Mar 31 22:41:04 GMT 2025 , Edited by admin on Mon Mar 31 22:41:04 GMT 2025
PRIMARY
SMS_ID
300000021742
Created by admin on Mon Mar 31 22:41:04 GMT 2025 , Edited by admin on Mon Mar 31 22:41:04 GMT 2025
PRIMARY
WIKIPEDIA
Lenzilumab
Created by admin on Mon Mar 31 22:41:04 GMT 2025 , Edited by admin on Mon Mar 31 22:41:04 GMT 2025
PRIMARY
FDA UNII
IE4X6497XK
Created by admin on Mon Mar 31 22:41:04 GMT 2025 , Edited by admin on Mon Mar 31 22:41:04 GMT 2025
PRIMARY
USAN
CD-127
Created by admin on Mon Mar 31 22:41:04 GMT 2025 , Edited by admin on Mon Mar 31 22:41:04 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109431
Created by admin on Mon Mar 31 22:41:04 GMT 2025 , Edited by admin on Mon Mar 31 22:41:04 GMT 2025
PRIMARY
NCI_THESAURUS
C125081
Created by admin on Mon Mar 31 22:41:04 GMT 2025 , Edited by admin on Mon Mar 31 22:41:04 GMT 2025
PRIMARY
ACTIVE MOIETY
LENZILUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966